Ibrutinib Protective against COVID-10 Pulmonary Damage?

[Lily_Pad_Master]

I just heard about this today at a forum. A very small convenience sample study of 6 Waldenstrom's patients at Dana-Farber/Brigham & Women's hospital who were also COVID-19 positive and symptomatic seemed to indicate that 420 mg of Ibrutinib might have been protected, or caused to recover from, hypoxia and serious lung damage. I think it's reasonable to assume our BTK inhibitors are about to be studied fairly intensely.

oncnet.com/news/ibrutinib-m...

[annmcgowan]

Hi thank you so much for posting this it is very encouraging.

Stay safe & well

Ann

[Lily_Pad_Master in reply to annmcgowan]

My pleasure, Ann. You too.

[Hidden]

Similar research is being done in Barcelona after a Dr spotted that no one with Covid 19, and who was taking Imbruvica, had been admitted.

[bennevisplace]

Clinical trials of Ibrutinib and Acalabrutinib (another BTK inhibitor) for the severe Covid indication are in progress

cllsociety.org/2020/04/ibru...

[Lily_Pad_Master in reply to bennevisplace]

Thank you!

[kathymac52]

thank you for the good news.....read it to my husband and he smiled!!!So much bad news lately, that he won't even watch the news.